We are delighted to announce the establishment of the Fat Rabbit MND Research Grant. It is our dream to find a cure for MND/ALS and every year, this grant will fund research that aims to facilitate development of a treatment.
2018 Recipient Announced - Professor Pamela McCombe
We are delighted to announce the recipient of the Fat Rabbit MND Research Grant this year is Professor Pamela McCombe. Professor McCombe will use the funds to further her work on novel biomarkers used in measuring progress of MND (Motor Neurone Disease). This is vital research in the quest to find causes of the disease.
Thank you to everyone who has purchased books and toys. All profits go to funding the annual grant. Special thanks to MND and Me and MND Australia for generously adding significant funding to make the Grant worthwhile. You guys rock!
Help us find a cure!
Donate to the Fat Rabbit MND Research Grant - there's no time to waste!
Motor neurone disease (MND) is the name given to a group of diseases in which the nerve cells (neurones) controlling the muscles that enable us to move, speak, breathe and swallow undergo degeneration and die.
Motor Neurone Disease (MND) is known as amyotrophic lateral sclerosis (ALS) in many parts of the world, and also as Lou Gehrig’s disease in the USA.
Motor function is controlled by the upper motor neurones in the brain that descend to the spinal cord; these neurones activate lower motor neurones. The lower motor neurones exit the spinal cord and directly activate muscles. With no nerves to activate them, muscles gradually weaken and waste. MND can affect a person’s ability to walk, speak, swallow and breathe.
There are an estimated 450,000 people worldwide living with MND. Every 90 minutes, someone else is diagnosed. But most people with MND only live 2-5 years after their first signs of disease. In order to help those who already have the disease, there is no time to waste.
Currently, there is only a single medicine for specifically treating ALS – riluzole. And even this drug, marketed by Sanofi-Aventis under the name Rilutek, only extends survival about 2 to 3 months. So there is currently an urgent, unmet medical need for effective treatments for this devastating and fatal disease.